Ceapro Inc: Rises after quarterly sales jump 20%

Ceapro

27/11/2020 16:10

** Canadian biotechnology company's shares  CZO.V  rise as
much as 4.35% to over one-week high of C$0.72
    ** Stock up for second straight session and is on track to
post biggest one-day gain in more than two weeks
    ** Posts a profit in Q3 vs a loss a year earlier, as sales
rise 20% to $C3.5 mln, helped by an increase in sales of its
flagship product, avenanthramides, in the United States
 urn:newsml:reuters.com:*:nGNX89w5JM
    ** Avenanthramides is a group of phenolic alkaloids that
provide anti-inflammatory and antioxidant benefits in humans and
animals
    ** YTD, CZO has jumped 121%

 (Reporting by Ankit Ajmera in Bengaluru)
 ((Ankit.Ajmera@thomsonreuters.com))